Preston Henske and Tim van Biesen, PhD
The pharmaceutical industry is no stranger to innovation--its very survival depends on it. In one area, though, the industry has...
Collaborating for Better R&D Productivity
Pooling multiple pharmaceutical companies' assets across a given therapeutic area will allow industry to make rational R&D investment decisions, expedite resource allocation and reduce investment in also-rans, eventually boosting productivity and improving a worsening reimbursement environment. Oncology may be a smart place to begin.